silver acetate has been researched along with silver in 12 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (16.67) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 9 (75.00) | 24.3611 |
| 2020's | 1 (8.33) | 2.80 |
| Authors | Studies |
|---|---|
| GHOSH, S; KRISHNA, B | 1 |
| Liu, SX; Wang, ZQ | 1 |
| Gao, X; Hadrup, N; Lam, HR; Larsen, A; Larsen, EH; Loeschner, K; Mortensen, A; Qvortrup, K; Vogel, U | 1 |
| Frandsen, H; Hadrup, N; Lam, HR; Larsen, EH; Loeschner, K; Mortensen, A | 1 |
| Conklin, S; Hunt, PR; Marquis, BJ; Nelson, BC; Olejnik, N; Sprando, RL; Tyner, KM | 1 |
| Hwang, K; Li, W; Lu, Y; Tan, LH; Wu, J; Wu, P; Xing, H | 1 |
| Cannon, CL; Cho, S; Li, R; Raymond, JE; Shah, PN; Smolen, JA; Wang, H; Wooley, KL; Zhang, F; Zhang, S | 1 |
| Ault, AP; Axson, JL; Bergin, IL; Capracotta, SS; Hashway, SA; Leroueil, PR; Maynard, AD; Morishita, M; Philbert, MA; Stark, DI; Walacavage, K; Wilding, LA | 1 |
| Argentiere, S; Aureli, F; Bianchessi, S; Cella, C; Cubadda, F; D'Amato, M; De Maglie, M; Lenardi, C; Mattiello, S; Milani, P; Raggi, A; Recordati, C; Scanziani, E | 1 |
| Black, SR; Fennell, TR; Harrington, JM; Holland, NA; Levine, KE; Mortensen, NP; Pathmasiri, W; Poitras, E; Snyder, RW; Sumner, SC; Wingard, CJ | 1 |
| Cannon, CL; Chen, Q; Chirra, B; DeBerardinis, RJ; Mullen, AR; Shah, KN; Shah, PN; Southerland, MR | 1 |
12 other study(ies) available for silver acetate and silver
| Article | Year |
|---|---|
SILVER acetate as a prophylactic for ophthalmia neonatorum.
Topics: Acetates; Biomedical Research; Coloring Agents; Humans; Infant, Newborn; Ophthalmia Neonatorum; Silver; Silver Compounds; Silver Nitrate | 1952 |
On the heterogeneous catalytic activity of colloidal silver in the reduction of silver acetate.
Topics: Acetates; Hydrogels; Silver; Silver Compounds | 1947 |
[Preparation and characterization of activated carbon-silver composite with antibacterial behavior via vacuum impregnation method].
Topics: Acetates; Anti-Bacterial Agents; Charcoal; Silver; Silver Compounds; Vacuum | 2011 |
Distribution of silver in rats following 28 days of repeated oral exposure to silver nanoparticles or silver acetate.
Topics: Acetates; Administration, Oral; Animals; Dose-Response Relationship, Drug; Female; Humans; Ileum; Materials Testing; Metal Nanoparticles; Particle Size; Random Allocation; Rats; Rats, Wistar; Silver; Silver Compounds; Tissue Distribution | 2011 |
Nanoparticulate silver increases uric acid and allantoin excretion in rats, as identified by metabolomics.
Topics: Acetates; Allantoin; Animals; Female; Male; Metabolomics; Metal Nanoparticles; Rats; Rats, Wistar; Silver; Silver Compounds; Uric Acid | 2012 |
Nanosilver suppresses growth and induces oxidative damage to DNA in Caenorhabditis elegans.
Topics: Acetates; Animals; Caenorhabditis elegans; Chemical Phenomena; Chromatography, Gas; DNA Damage; DNA, Helminth; Dose-Response Relationship, Drug; Endpoint Determination; Ions; Larva; Metal Nanoparticles; Oxidative Stress; Silver; Silver Compounds; Tandem Mass Spectrometry; Toxicity Tests | 2013 |
DNA sequence-dependent morphological evolution of silver nanoparticles and their optical and hybridization properties.
Topics: Acetates; Ascorbic Acid; Base Sequence; DNA; Metal Nanoparticles; Nanotechnology; Nucleic Acid Hybridization; Optical Phenomena; Silver; Silver Compounds | 2014 |
Degradable polyphosphoester-based silver-loaded nanoparticles as therapeutics for bacterial lung infections.
Topics: Acetates; Anti-Bacterial Agents; Bacterial Infections; Biocompatible Materials; Bronchi; Cations; Cystic Fibrosis; Drug Delivery Systems; Drug Design; Epithelial Cells; Humans; Lung Diseases; Metal Nanoparticles; Micelles; Microbial Sensitivity Tests; Microscopy, Electron, Transmission; Nanotechnology; Polymers; Silver; Silver Compounds; Solubility; Spectrum Analysis, Raman; Water | 2015 |
Effects of particle size and coating on toxicologic parameters, fecal elimination kinetics and tissue distribution of acutely ingested silver nanoparticles in a mouse model.
Topics: Acetates; Animals; Body Weight; Citric Acid; Dose-Response Relationship, Drug; Feces; Kinetics; Male; Metal Nanoparticles; Mice; Models, Animal; Organ Size; Particle Size; Polyvinyls; Pyrrolidines; Silver; Silver Compounds; Tissue Distribution | 2016 |
Tissue distribution and acute toxicity of silver after single intravenous administration in mice: nano-specific and size-dependent effects.
Topics: Acetates; Animals; Brain; Chemical and Drug Induced Liver Injury; Citric Acid; Gallbladder Diseases; Hemorrhage; Injections, Intravenous; Kidney; Liver; Lung; Male; Mice, Inbred ICR; Nanoparticles; Necrosis; Particle Size; Povidone; Risk Assessment; Silver; Silver Compounds; Spleen; Tissue Distribution | 2016 |
Disposition of intravenously or orally administered silver nanoparticles in pregnant rats and the effect on the biochemical profile in urine.
Topics: Acetates; Administration, Intravenous; Administration, Oral; Adult; Cardiovascular Diseases; Cytokines; Female; Fetus; Humans; Maternal-Fetal Exchange; Metabolomics; Metal Nanoparticles; Oxidative Stress; Particle Size; Placenta; Pregnancy; Silver; Silver Compounds; Tissue Distribution | 2017 |
N-Acetyl cysteine abrogates silver-induced reactive oxygen species in human cells without altering silver-based antimicrobial activity.
Topics: Acetates; Acetylcysteine; Adenosine Triphosphate; Anti-Bacterial Agents; Ascorbic Acid; Cell Line; Free Radical Scavengers; Gas Chromatography-Mass Spectrometry; Glutathione; Humans; Melatonin; Microbial Sensitivity Tests; Reactive Oxygen Species; Silver; Silver Compounds; Superoxides | 2020 |